Natco Pharma has seen a big breakout of around six-week consolidation with strong volumes. The stock has also seen a crossover with 50-day EMA crossing the 200-day EMA in the week gone by, which is a positive sign.
Nilesh Shah believes competitive companies catering to local and global markets will do well in the days, months, quarters and years to come. He also adds that he is bullish on the manufacturing sector in India.